Amlodipine inhibits thapsigargin-sensitive Ca2+ stores in thrombin-stimulated vascular smooth muscle cells

26Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Ca2+ channel blockers, such as amlodipine, inhibit vascular smooth muscle cell (VSMC) growth through interactions with targets other than L-type Ca2+ channels. The effects of amlodipine on Ca2+ movements in thrombin- and thapsigargin-stimulated VSMCs were therefore investigated by determining the variations of intracellular free Ca2+ concentration in fura 2-loaded cultured VSMCs. Results indicated that 10-1,000 nM amlodipine inhibited 1) thrombin-induced Ca2+ mobilization from a thapsigargin-sensitive pool and 2) thapsigargin-induced Ca2+ responses, including Ca2+ mobilization from internal stores and store-operated Ca2+ entry. These effects of amlodipine do not involve L-type Ca2+ channels and could not be reproduced with 100 nM isradipine, diltiazem, or verapamil. The inhibition by amlodipine of Ca2+ mobilization appears therefore to be a specific property of the drug, in addition to its Ca2+ channel-blocking property. It is suggested that amlodipine acts in this capacity by interacting with Ca2+-ATPases of the sarcoplasmic reticulum, thus modulating the enzyme activity. This mechanism might participate in the inhibitory effect of amlodipine on VSMC growth.

Cite

CITATION STYLE

APA

Stepien, O., & Marche, P. (2000). Amlodipine inhibits thapsigargin-sensitive Ca2+ stores in thrombin-stimulated vascular smooth muscle cells. American Journal of Physiology - Heart and Circulatory Physiology, 279(3 48-3). https://doi.org/10.1152/ajpheart.2000.279.3.h1220

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free